1-3 of 3
Kevin J. Anstrom
Close
Sort by
Journal Articles

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Lisa Baumann Kreuziger, Taeim Kwon, Lana Wahid, Raj S. Kasthuri, Andrei L. Kindzelski, M. Margaret Knudson, Jerry Krishnan, Gervasio Lamas, Eric Leifere, Jose Lopez-Sendon, Peter J Miller, Bela Patel, Alexandra J Weissman, John Quigley, Deborah Siegal, Tracy Y Wang, Kevin J Anstrom, Thomas L. Ortel
Journal: Blood
Blood (2023) 142 (Supplement 1): 2630.
https://doi.org/10.1182/blood-2023-190552
Published: 2023
Journal Articles

Updated Cost-Effectiveness Analysis of First-Line Imatinib Compared to Interferon-α in Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Chronic Phase Using 60-Month Data from IRIS.

Shelby D. Reed, PhD, Kevin J. Anstrom, PhD, Yanhong Li, MS, Kevin A. Schulman, MD
Journal: Blood
Blood (2006) 108 (11): 3312.
https://doi.org/10.1182/blood.V108.11.3312.3312
Published: 2006
Journal Articles

Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry.

Stephan Moll, MD, Charles S. Abrams, MD, Lawrence Rice, MD, Richard C. Becker, MD, Peter B. Berger, MD, Kevin J. Anstrom, Emily F. Honeycutt, Eric M. Crespo, MD, Chris Granger, MD, David J. Moliterno, MD, Jo E. Rodgers, pharmD, Steven R. Steinhubl, MD, Victor F. Tapson, MD, Magnus Ohman, MD
Journal: Blood
Blood (2004) 104 (11): 2197.
https://doi.org/10.1182/blood.V104.11.2197.2197
Published: 2004